Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS-CoV-2 spike protein vaccine as a homologous and heterologous booster vaccination: A randomized placebo-controlled trial
Immunology (2022) - Comments
pubmed: 35758850  doi: 10.1111/imm.13540  issn: 0019-2805  issn: 1365-2567 

Payam Tabarsi, Nassim Anjidani, Ramin Shahpari, Khashayar Roshanzamir, Newsha Fallah, Greiciely Andre, Nikolai Petrovsky, Saghar Barati